A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others

Cancer Biology and Therapy

Volumn 4, Issue 4, 2005, Pages 446-454

  Nishiyama, Rie ^a,e   Qi, Lixin ^a   Tsumagari, Koji ^a   Weissbecker, Karen ^a   Dubeau, Louis ^b   Champagne, Martin ^c   Sikka, Suresh ^a   Nagai, Hisaki ^d   Ehrlich, Melanie ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer; DNA hypermethylation; DNA hypomethylation; DNA repeats

Indexed keywords

DNA; DNA METHYLTRANSFERASE 3B; PROTEIN NBL2; REPETITIVE DNA; UNCLASSIFIED DRUG;

ACROCENTRIC CHROMOSOME; ARTICLE; CANCER; CARCINOGENESIS; CONTROLLED STUDY; CYSTADENOMA; DISEASE SEVERITY; DNA METHYLATION; DNA SEQUENCE; ENZYME DEFICIENCY; EPIGENETICS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TANDEM REPEAT;

EID: 25144463972     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.4.1622     Document Type: Article

References (49)

1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89-92.
2. Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983; 111:47-54.
3. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983; 11:6883-94.
4. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28.
5. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C. Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nat Genet 2000; 24:132-8.
6. Ehrlich M. DNA methylation in cancer: Too much, but also too little. Oncogene 2002; 21:5400-13.
7. Wong N, Lam WC, Lai PB, Pang E, Lau WY, Johnson PJ. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 2001; 159:465-71.
8. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci USA 2002; 99:10060-5.
9. Yamamoto F, Yamamoto M, Soto JL, Kojima E, Wang EN, Perucho M, Sekiya T, Yamanaka H. Notl-Msell methylation-sensitive amplied fragment length polymorhism for DNA methylation analysis of human cancers. Electrophoresis 2001; 22:1946-56.
10. Tsuda H, Takarabe T, Kanai Y, Fukutomi T, Hirohashi S. Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am J Pathol 2002; 161:859-66.
11. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer 1997; 75:396-402.
12. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 2001; 61:4238-4243.
13. Kim Y-I, Giuliano A, Hatch KD, Schneider A, Nour MA, Dallal GE, Selhub J, Mason JB. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 1994; 74:893-9.
14. Soares J, Pinto AE, Cunha CV, Andre S, Barao I, Sousa JM, Cravo M. Global DNA hypomethylation in breast carcinoma: Correlation with prognostic factors and tumor progression. Cancer 1999; 85:112-8.
15. Eads CA, Nickel AE, Laird PW. Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice. Cancer Res 2002; 62:1296-9.
16. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
17. Carr BI, Reilly G, Smith SS, Winberg C, Riggs A. The tumorigenicity of 5-azacytidine in the male Fisher rat. Carcinogenesis 1984; 5:1583-90.
18. Denda A, Rao PM, Rajalakshmi S, Sarma DS. 5-azacytidine potentiates initiation induced by carcinogens in rat liver. Carcinogenesis 1985; 6:145-146.
19. Thomas GA, Williams ED. Production of thyroid tumours in mice by demethylating agents. Carcinogenesis 1992; 13:1039-42.
20. Qu G, Dubeau L, Narayan A, Yu M, Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mut Res 1999; 423:91-101.
21. Ehrlich M, Jiang G, Fiala ES, Dome JS, Yu MS, Long TI, Youn B, Sohn O-S, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, Parham DM, Liang G, Malik K, Laird PW. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002; 21:6694-702.
22. Narayan A, Ji W, Zhang X-Y, Marrogi A, Graff JR, Baylin SB, Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77:833-8.
23. Qu G, Grundy PE, Narayan A, Ehrlich M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 1999; 109:34-9.
24. Ehrlich M, Hopkins N, Jiang G, Dome JS, Yu MS, Woods CB, Tomlinson GE, Chintagumpala M, Champagne M, Diller L, Parham DM, Sawyer J. Satellite hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet 2003; 141:97-105.
25. Widschwendter M, Jiang G, Woods C, Muller HM, Fiegl H, Goebel G, Marth C, Holzner EM, Zeimet AG, Laird PW, Ehrlich M. DNA hypomethylation and ovarian cancer biology. Cancer Res 2004; 64:4472-80.
26. Itano O, Ueda M, Kikuchi K, Hashimoto O, Hayatsu S, Kawaguchi M, Seki H, Aiura K, Kitajima M. Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences. Oncogene 2002; 21:789-97.
27. Nagai H, Kim YS, Yasuda T, Ohmachi Y, Yokouchi H, Monden M, Emi M, Konishi N, Nogami M, Okumura K, Matsubara K. A novel sperm-specific hypomethylation sequence is a demethylation hotspot in human hepatocellular carcinomas. Gene 1999; 237:15-20.
28. Thoraval D, Asakawa J, Kodaira M, Chang C, Radany E, Kuick R, Lamb B, Richardson B, Neel JV, Glover T, Hanash S. A methylated human 9-kb repetitive sequence on acrocentric chromosomes is homologous to a subtelomeric repeat in chimpanzees. Proc Natl Acad Sci USA 1996; 93:4442-7.
29. Thoraval D, Asakawa J, Wimmer K, Kuick R, Lamb B, Richardson B, Ambros P, Glover T, Hanash S. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer 1996; 17:234-44.
30. Nagai H, Ponglikitmongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, Yumoto Y, Nakanishi T, Matsubara K. Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 1994; 54:1545-50.
31. Ehrlich M, Buchanan K, Tsien F, Jiang G, Sun B, Uicker W, Weemaes C, Smeets D, Sperling K, Belohradsky B, Tommerup N, Misek D, Rouillard J-M, Kuick R, Hanash S. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphocyte migration, activation, and survival genes. Hum Mol Genet 2001; 10:2917-31.
32. Ehrlich M, Gama-Sosa M, Huang L-H, Midgett RM, Kuo KC, McCune RA, Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res 1982; 10:2709-21.
33. Lemmers RJL, de Kievit P, van Geel M, van der Wielen MJ, Bakker E, Padberg GW, Frants RR, van der Maarel SM. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 2001; 50:816-9.
34. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003; 12:2909-21.
35. Kondo T, Comenge Y, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Pequinot E, Ehrlich M, Hanash S. Whole-genome methylation scan in ICF syndrome: Hypomethylation of nonsatellite DNA repeats D4Z4 and NBL2. Hum Mol Gen 2000; 9:597-604.
36. Ehrlich M, Tsien F, Herrera D, Blackman V, Roggenbuck J, Tuck-Muller CM. High frequencies of ICF syndrome-like pericentromeric heterochromatin decondensation and breakage in chromosome 1 in a chorionic villus sample. J Med Genet 2001; 38:882-884.
37. Zheng J, Benedict WF, Xu HJ, Hu SX, Kim TM, Velicescu M, Wan M, Cofer KF, Dubeau L. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J Natl Cancer Inst 1995; 87:1146-53.
38. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 2001; 33:561-8.
39. Jackson K, Yu M, Arakawa K, Fiala E, Youn B, Fiegl H, Muller-Holzner E, Widschwendter M, Ehrlich M. DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 2004; 3:1225-31.
40. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes? Gynecol Oncol 1999; 72:437-42.
41. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 1999; 80:1312-21.
42. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB, Issa JP. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59:2307-12.
43. Yan PS, Rodriguez FJ, Laux DE, Perry MR, Standiford SB, Huang TH. Hypermethylation of ribosomal DNA in human breast carcinoma. Br J Cancer 2000; 82:514-7.
44. Kim YS, Yoo HS, Lee KT, Goh SH, Jung JS, Oh SW, Baba M, Yasuda T, Matsubara K, Nagai H. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA. Int J Oncol 2000; 17:297-308.
45. Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ. Ribosomal DNA methylation in patients with endometrial carcinoma: An independent prognostic marker. Cancer 2002; 94:2941-52.
46. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99:3740-5.
47. Sorek R, Safer HM. A novel algorithm for computational identification of contaminated EST libraries. Nucleic Acids Res 2003; 31:1067-74.
48. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 2004; 64:3871-7.
49. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY. Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001; 20:3814-23.